Presentation
17 March 2023 The potential application of PS-OCT in the safety assessment of non-steroidal topical creams for atopic dermatitis treatment
Author Affiliations +
Abstract
Crisaborole 2% ointment is a non-steroidal treatment for mild-moderate atopic dermatitis (AD) and may have a better safety profile than topical corticosteroids (TCS), which produce pronounced epidermal atrophy. In this study we compared crisaborole to betamethasone valerate (BMV) in terms of changes to dermal collagen, using PS-OCT to quantify dermal birefringence. 37 subjects were enrolled in this study, which involved daily application of BMV & crisaborole. Results showed BMV produced a significant increase in dermal birefringence, whereas crisaborole showed no significant change. PS-OCT may thus have an important role in the safety assessment of non-steroidal alternatives to TCS.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Mengqiu Duan, Robert Byers, Simon G. Danby, Rosie N. Taylor, Amy Cha, Roni Adiri, Chuanbo Zang, John Werth, Michael J. Cork, and Stephen J. Matcher "The potential application of PS-OCT in the safety assessment of non-steroidal topical creams for atopic dermatitis treatment", Proc. SPIE PC12352, Photonics in Dermatology and Plastic Surgery 2023, PC123520F (17 March 2023); https://doi.org/10.1117/12.2647545
Advertisement
Advertisement
KEYWORDS
Safety

Collagen

Image segmentation

Optical coherence tomography

Birefringence

Microscopy

Second-harmonic generation

Back to Top